A cultural approach to dementia

Highlighting the need to integrate cultural factors into dementia research and care

Announcements

Advertisement

Treatment of multiple sclerosis

The first disease-modifying therapy for relapsing–remitting multiple sclerosis — interferon‑β 1b — was approved by the FDA in 1993. The following 25 years have seen rapid expansion of the therapeutic options as an evolving understanding of the disease has enabled development of therapies with different modes of action.
Milestone

Advertisement

Nature Careers

Events

Advertisement